Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Outcomes of Phase I Trial of Patients With Recurrent Head and Neck Squamous Cell Carcinoma Treated With Re-Irradiation With Stereotactic Body Radiation Therapy and Concurrent Cisplatin

M Echevarria,C Chung,K Kirtane,J A Kish,J Muzaffar,J J Caudell

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS（2021）

Cited 0|Views5
No score
Abstract
Patients with recurrent head and neck cancer typically present with advanced, unresectable disease, and therefore have limited definitive treatment options. This phase I study demonstrates that SBRT with concurrent Cisplatin provides reasonable locoregional control and overall survival with radiation doses of 40 Gy.
More
Translated text
Key words
stereotactic body re-irradiation therapy,neck squamous cell carcinoma,re-irradiation therapy,squamous cell carcinoma,recurrent head
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined